Two Air India Group pilots return non-negative results in initial drug screening

Air India Group has expanded mandatory psychoactive-substance testing for pilots after the August 4 turbulence incident on flight AI2379. About 400 pilots have been screened so far; two received non-negative initial results, pending confirmatory testing.

— Source published Mon, 17 Aug, 2026, 15:48 IST · First seen Mon, 17 Aug, 2026, 15:51 IST · Source Outlook Business

What happened

Two Air India Group pilots returned non-negative initial drug-test results after the Tata-owned airlines expanded mandatory psychoactive substance screening for

Key facts

  • 2 pilots received non-negative initial drug-test results
  • Around 400 pilots tested so far
  • Air India Group has more than 5,000 pilots
  • AI2379 lost about 300 feet (91 metres) altitude
  • 145 people were on board: 137 passengers and 8 crew
  • At least 24 people were injured

Why this matters

For potential partners and acquisition targets, Air India Group’s heightened screening underscores that safety-governance standards, compliance controls, and workforce-risk processes will be central diligence considerations.

What to watch

  • Confirmatory test results and whether either pilot is named, suspended, or terminated.
  • DGCA statements, audits, directives, or penalties related to the AI2379 turbulence event or pilot testing.
  • The total number of pilots screened, rate of non-negative findings, and any expansion to cabin crew or maintenance staff.
  • Flight cancellations, delays, or crew-shortage indicators at Air India Group.
  • Passenger demand, corporate-travel sentiment, and social-media attention around Air India safety.
  • Complete confirmatory laboratory testing and keep affected pilots off flight duty pending results.
  • Expand random and post-incident psychoactive-substance screening across Air India, Air India Express, and related crew pools.
  • Review fatigue, roster, mental-health, and prescription-medication reporting systems alongside drug-testing controls.
  • Coordinate disclosures with DGCA and communicate that initial non-negative results are not confirmed violations.
  • Build reserve-crew capacity in case expanded screening or suspensions create scheduling gaps.